MacroGenics
MGNX
89 hedge funds and large institutions have $332M invested in MacroGenics in 2014 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 44 increasing their positions, 14 reducing their positions, and 14 closing their positions.
214% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 14
100% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 14
19% more funds holding
Funds holding: 75 → 89 (+14)
3.37% more ownership
Funds ownership: 51.76% → 55.13% (+3.4%)
0% more capital inflows, than outflows
Capital inflows: $150M | Capital outflows: $150M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$27.3M |
| 2 |
First Eagle Investment Management
New York
|
+$7.03M |
| 3 |
Private Capital Advisors
Darien,
Connecticut
|
+$6.97M |
| 4 |
BlackRock Fund Advisors
San Francisco,
California
|
+$6.68M |
| 5 |
BlackRock Institutional Trust
San Francisco,
California
|
+$4.64M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MPM Asset Management
Boston,
Massachusetts
|
-$37.4M |
| 2 |
Caisse de Depot et Placement du Quebec (CDPQ)
Montreal,
Quebec, Canada
|
-$30.9M |
| 3 |
TPG Group Holdings (SBS) Advisors
Fort Worth,
Texas
|
-$20.8M |
| 4 |
OrbiMed
New York
|
-$13.7M |
| 5 |
PFM Health Sciences
San Francisco,
California
|
-$5.82M |
MGNX Hedge Fund Activity: Q2 2014 in Review
89 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q2 2014, worth a combined $332M — down 16% from $398M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new MGNX positions and 14 closed out — a net gain of 14 holders — while 44 added to existing stakes and 14 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $27.3M. The largest seller was MPM Asset Management, cutting an estimated $37.4M.
- 89 institutional investors held MacroGenics (MGNX) as of Q2 2014, up from 75 in Q1 2014.
- Funds reported $332M of MacroGenics stock for Q2 2014, down 16% quarter-over-quarter.
- 28 funds opened new MacroGenics positions in Q2 2014 and 14 closed out, a net change of +14 holders.
- The largest MacroGenics buyer in Q2 2014 was Fidelity Investments, an estimated $27.3M added.
- The largest MacroGenics seller in Q2 2014 was MPM Asset Management, an estimated $37.4M sold.
Based on aggregated 13F filings for Q2 2014.